BioSante Pharmaceuticals, Inc. (BPAX)

[Just the facts maam]

Report shows 101 Cancer vaccine in various stages of development

Biosante presently has 7 GVAX type vaccines, breast, clorectal, leukemia, myeloma, pancreatic and prostate.

I note that only a few big pharma are developing cancer vaccines,this supports previous reports that I have read, that companies are farming out R & D.

This should eventually bode well for Biosante with 7% of all cancer vaccines under development and presently in 17 clinical trials. There will be a number of Big Pharma seriously looking at the company. The CEOs are under pressure to improve their R&D and some are being shown the door for failed bids. Cancer vaccines have only been approved since 2010 so this is becoming a large growth market opportunity.

Vaccine development report

Note: the GVAX prostate was listed as Phase III Fast Track. I believe they are referring to Phase III trials that were conducted by Cell Cenesys.